Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

Overview

About this study

This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

be between18 to 89 years old;
have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery)
have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study;
be native speakers of American English;
have obtained a minimum of a high school education;
self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and
must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool.

Exclusion Criteria:

are younger than 18 years old or older than 89 years old;
have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery)
have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment;
are not native speakers of American English;
have not obtained a minimum of a high school education;
do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or
do not demonstrate the capacity to sign informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Nadia Laack, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Nadia Laack, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials